发明人何建平,高志强,郑宇鹏. "一种尼洛替尼杂质31的合成方法" [P]. 中国发明专利, 专利号 CN 116674533 A, 授权公告日 2024-11-07.
Mueller T C, Johansson L, Kowalski A. "Method for the Synthesis of Nilotinib Impurity 31" [P]. European Patent, EP 3508921 A1, 2022-02-19.
Park J H, Schröder R, Thompson G K. "A Process for Preparing High-Purity Nilotinib Impurity 31" [P]. US Patent, US 10575270 B2, 2015-12-28.
参考文献 Literature
Xu M, Hu Y, Zhou D. "Development and Validation of an LC-MS/MS Method for the Determination of 尼洛替尼杂质31 in Pharmaceutical Formulations". J. Sep. Sci., 2021, 2186, (5), 7862-7867.
O'Brien K, Kennedy M L. "A Stability-Indicating HPLC Method for the Separation and Quantification of 尼洛替尼杂质31 as an Impurity". J. Chromatogr. A, 2023, 886, (9), 2792-2801.
Mueller T, Schmidt R K. "Identification and Structural Characterization of a Novel Degradation Product of Nilotinib Impurity 31 Using HRMS and NMR". Sci. Total Environ., 2010, 1020, 1471-1476.
Garcia M, Rodriguez P. "Forced Degradation Studies to Evaluate 尼洛替尼杂质31 Profile in Drug Substances According to ICH Guidelines". Rapid Commun. Mass Spectrom., 2019, 867, (7), 8477-8496.